3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
22
Rectal Neoplasms
8
Colonic Neoplasms
7
Neoplasms
5
Neoplasm Metastasis
3
Ovarian Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Gastrointestinal Neoplasms
1
Exanthema
1
Colorectal Cancer Metastatic
1
Carcinoma, Basal Cell
1
Advanced Solid Tumor
1
Adenocarcinoma
1
Interventions
Radiotherapy
11
Cisplatin
10
Paclitaxel
9
pembrolizumab
7
Fluorouracil
7
Oxaliplatin
6
Irinotecan
6
tislelizumab
5
Cetuximab
5
Docetaxel
4
Radiation
3
Nivolumab
3
Leucovorin
3
Carboplatin
3
Capecitabine
3
Neoadjuvant Therapy
2
Immunohistochemistry
2
Biopsy
2
10-propargyl-10-deazaaminopterin
2
tremelimumab
1
sitravatinib
1
sintilimab
1
regorafenib
1
pegylated granulocyte colony-stimulating factor, human
1
pegfilgrastim
1
oblimersen
1
durvalumab
1
cixutumumab
1
adavosertib
1
Taxes
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Esophageal Squamous Cell Carcinoma
×
IFL protocol
×
Clear all
No trials found.